DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancer.
Moskovich D, Alfandari A, Finkelshtein Y, Weisz A, Katzav A, Kidron D, Edelstein E, Veroslavski D, Perets R, Arbib N, Kadan Y, Fishman A, Lerer B, Ellis M, Ashur-Fabian O.
Moskovich D, et al. Among authors: katzav a.
Cancer Lett. 2021 Mar 31;501:224-233. doi: 10.1016/j.canlet.2020.11.011. Epub 2020 Nov 19.
Cancer Lett. 2021.
PMID: 33221455